These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23648444)

  • 1. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer.
    Hagleitner MM; Coenen MJ; Aplenc R; Patiño-Garcia A; Chiusolo P; Gemmati D; De Mattei M; Ongaro A; Krajinovic M; Hoogerbrugge PM; Vermeulen SH; te Loo DM
    Pharmacogenomics J; 2014 Apr; 14(2):115-9. PubMed ID: 23648444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
    Zhou Y; He H; Ding L; Wang T; Liu X; Zhang M; Zhang A; Fu J
    Eur J Pediatr; 2024 Feb; 183(2):581-590. PubMed ID: 37851084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate elimination and toxicity: MTHFR 677C>T polymorphism in patients with primary CNS lymphoma treated with high-dose methotrexate.
    Choi YJ; Park H; Lee JS; Lee JY; Kim S; Kim TW; Park JS; Kim JE; Yoon DH; Suh C
    Hematol Oncol; 2017 Dec; 35(4):504-509. PubMed ID: 27781293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose methotrexate treatment in childhood ALL: pilot study on the impact of the MTHFR 677C>T and 1298A>C polymorphisms on MTX-related toxicity.
    Haase R; Elsner K; Merkel N; Stiefel M; Mauz-Körholz C; Kramm CM; Körholz D
    Klin Padiatr; 2012 Apr; 224(3):156-9. PubMed ID: 22513795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MTHFR C677T Polymorphism on High-Dose Methotrexate-Related Toxicity in Patients With Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
    Chang X; Guo Y; Su L; Zhang Y; Hui W; Zhao H; Hu R; Sun W
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):91-96. PubMed ID: 33069634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for the MTHFR 677C>T and 1298A>C polymorphisms in methotrexate-induced liver toxicity?
    te Loo DM; Hagleitner MM; Coenen MJ
    Pharmacogenomics; 2014 Aug; 15(11):1401-3. PubMed ID: 25303291
    [No Abstract]   [Full Text] [Related]  

  • 7. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
    Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
    Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
    Schmeling H; Biber D; Heins S; Horneff G
    J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
    Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
    Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice.
    Celtikci B; Leclerc D; Lawrance AK; Deng L; Friedman HC; Krupenko NI; Krupenko SA; Melnyk S; James SJ; Peterson AC; Rozen R
    Pharmacogenet Genomics; 2008 Jul; 18(7):577-89. PubMed ID: 18551038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.
    Kałużna E; Strauss E; Zając-Spychała O; Gowin E; Świątek-Kościelna B; Nowak J; Fichna M; Mańkowski P; Januszkiewicz-Lewandowska D
    Eur J Pharmacol; 2015 Dec; 769():93-9. PubMed ID: 26528799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy].
    Liao QC; Li XL; Liu ST; Zhang Y; Li TY; Qiu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):735-9. PubMed ID: 22968027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.
    Müller J; Kralovánszky J; Adleff V; Pap E; Németh K; Komlósi V; Kovács G
    Anticancer Res; 2008; 28(5B):3051-4. PubMed ID: 19031955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
    Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
    Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between MTHFR 677C/T polymorphism and psoriasis risk: a meta-analysis.
    Qi JH; Qi JH; Shi N; Chen YJ; Nie G
    Genet Mol Res; 2015 Apr; 14(2):3869-76. PubMed ID: 25966157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis.
    van Beynum IM; den Heijer M; Blom HJ; Kapusta L
    QJM; 2007 Dec; 100(12):743-53. PubMed ID: 17965089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
    Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
    Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.